Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 80, n° 6
pages e163-e164 (juin 2019)
Doi : 10.1016/j.jaad.2018.12.032
Notes & Comments

Response to: “Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?”
 

Brian R. Gastman, MD a, Robert W. Cook, PhD b,
a Department of Plastic Surgery, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio 
b Castle Biosciences, Inc, Friendswood, Texas 

Correspondence to: Robert W. Cook, PhD, 820 S Friendswood Dr, Suite 210, Friendswood, TX 77546820 S Friendswood Dr, Suite 210FriendswoodTX77546

 Funding sources: None.
 Disclosure: Dr Gastman serves on the speaker bureau of Castle Biosciences, Inc, and Dr Cook is an employee and option holder of Castle Biosciences, Inc.


Top of the page

© 2018  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@